Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA PANACEA BIOTECH CIPLA/
PANACEA BIOTECH
 
P/E (TTM) x 33.7 0.7 4,493.8% View Chart
P/BV x 4.3 1.0 421.8% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 CIPLA   PANACEA BIOTECH
EQUITY SHARE DATA
    CIPLA
Mar-22
PANACEA BIOTECH
Mar-22
CIPLA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,083454 238.7%   
Low Rs806148 544.7%   
Sales per share (Unadj.) Rs269.7108.0 249.9%  
Earnings per share (Unadj.) Rs31.7176.0 18.0%  
Cash flow per share (Unadj.) Rs44.8183.1 24.4%  
Dividends per share (Unadj.) Rs5.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs257.8138.6 186.0%  
Shares outstanding (eoy) m806.8161.25 1,317.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.52.8 125.7%   
Avg P/E ratio x29.81.7 1,741.9%  
P/CF ratio (eoy) x21.11.6 1,284.5%  
Price / Book Value ratio x3.72.2 168.8%  
Dividend payout %15.80-   
Avg Mkt Cap Rs m762,17718,427 4,136.1%   
No. of employees `000NANA-   
Total wages/salary Rs m35,2991,829 1,929.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,6336,612 3,291.3%  
Other income Rs m3,217110 2,933.1%   
Total revenues Rs m220,8516,722 3,285.5%   
Gross profit Rs m43,29816,623 260.5%  
Depreciation Rs m10,520437 2,409.4%   
Interest Rs m1,0641,808 58.8%   
Profit before tax Rs m34,93314,488 241.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3383,709 251.8%   
Profit after tax Rs m25,59510,779 237.4%  
Gross profit margin %19.9251.4 7.9%  
Effective tax rate %26.725.6 104.4%   
Net profit margin %11.8163.0 7.2%  
BALANCE SHEET DATA
Current assets Rs m147,10810,406 1,413.8%   
Current liabilities Rs m49,1298,028 612.0%   
Net working cap to sales %45.036.0 125.2%  
Current ratio x3.01.3 231.0%  
Inventory Days Days6361 103.3%  
Debtors Days Days673 7.9%  
Net fixed assets Rs m119,4157,118 1,677.7%   
Share capital Rs m1,61461 2,634.4%   
"Free" reserves Rs m206,3648,427 2,448.9%   
Net worth Rs m207,9778,488 2,450.3%   
Long term debt Rs m4,162341 1,220.5%   
Total assets Rs m266,52317,523 1,521.0%  
Interest coverage x33.89.0 375.6%   
Debt to equity ratio x00 49.8%  
Sales to assets ratio x0.80.4 216.4%   
Return on assets %10.071.8 13.9%  
Return on equity %12.3127.0 9.7%  
Return on capital %17.0184.6 9.2%  
Exports to sales %26.218.2 143.9%   
Imports to sales %8.222.4 36.4%   
Exports (fob) Rs m57,0941,205 4,737.0%   
Imports (cif) Rs m17,8031,484 1,199.4%   
Fx inflow Rs m60,1801,236 4,870.4%   
Fx outflow Rs m17,8031,735 1,026.2%   
Net fx Rs m42,376-499 -8,486.1%   
CASH FLOW
From Operations Rs m33,259-1,084 -3,067.2%  
From Investments Rs m-18,71912,826 -145.9%  
From Financial Activity Rs m-15,998-11,759 136.1%  
Net Cashflow Rs m-1,323-17 7,653.0%  

Share Holding

Indian Promoters % 13.5 73.6 18.3%  
Foreign collaborators % 20.1 0.0 -  
Indian inst/Mut Fund % 49.4 0.4 11,481.4%  
FIIs % 27.7 0.1 19,771.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 26.4 251.4%  
Shareholders   388,864 49,078 792.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    


More on Cipla vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Panacea Biotech Share Price Performance

Period Cipla Panacea Biotech S&P BSE HEALTHCARE
1-Day -0.35% 2.74% 0.23%
1-Month -4.65% -3.17% 0.36%
1-Year 14.22% -33.85% -6.87%
3-Year CAGR 33.00% 3.73% 20.16%
5-Year CAGR 12.52% -12.89% 11.07%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.6% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 15.8%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Cipla, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.